Catalogo dei prodotti della ricerca

MUSUMECI, Maria Beatrice
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.398
EU - Europa 1.608
AS - Asia 995
AF - Africa 45
SA - Sud America 27
OC - Oceania 15
Totale 7.088
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.349
IT - Italia 636
SG - Singapore 539
IN - India 221
DE - Germania 178
SE - Svezia 169
CN - Cina 141
FI - Finlandia 117
AT - Austria 89
IE - Irlanda 65
UA - Ucraina 63
GB - Regno Unito 57
ID - Indonesia 49
BG - Bulgaria 48
TG - Togo 41
CA - Canada 40
FR - Francia 40
RU - Federazione Russa 36
BE - Belgio 30
RO - Romania 27
AU - Australia 15
NL - Olanda 14
AR - Argentina 11
TR - Turchia 10
LT - Lituania 9
MX - Messico 9
RS - Serbia 9
HK - Hong Kong 8
BR - Brasile 7
CO - Colombia 5
MD - Moldavia 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
BA - Bosnia-Erzegovina 3
BD - Bangladesh 3
CL - Cile 3
EG - Egitto 3
GR - Grecia 3
TW - Taiwan 3
EE - Estonia 2
IR - Iran 2
KR - Corea 2
PH - Filippine 2
PK - Pakistan 2
AZ - Azerbaigian 1
BO - Bolivia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
HR - Croazia 1
IL - Israele 1
JO - Giordania 1
JP - Giappone 1
LV - Lettonia 1
MY - Malesia 1
SA - Arabia Saudita 1
TH - Thailandia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 7.088
Salva come PNG Salva come JPEG
Città #
Fairfield 677
Singapore 420
Ashburn 361
Seattle 295
Woodbridge 294
Chandler 289
Houston 258
Rome 252
Cambridge 241
Wilmington 220
Santa Clara 155
Princeton 114
San Paolo di Civitate 101
Ann Arbor 99
Lawrence 82
Vienna 77
Plano 72
San Diego 66
Beijing 61
New York 59
Dearborn 58
Boston 57
Millbury 52
Sofia 48
Helsinki 47
Jakarta 47
Dublin 46
Lomé 41
Milan 33
Andover 32
Boardman 23
Fremont 22
Norwalk 20
Ottawa 20
Moscow 19
Brussels 18
Jacksonville 18
London 18
Toronto 17
Lappeenranta 16
Des Moines 15
Los Angeles 15
Frankfurt am Main 14
Washington 13
Bremen 12
Liège 12
San Mateo 12
Bühl 10
Federal 10
Istanbul 10
Pune 10
Adelaide 9
Dallas 8
Falkenstein 8
Kunming 8
Mannheim 8
Shanghai 8
Hefei 7
Hong Kong 7
Nellore 7
Colorado Springs 6
Falls Church 6
Fasano 6
Bergamo 5
Chisinau 5
Menlo Park 5
Oxford 5
Calcio 4
Chongqing 4
Florence 4
Genova 4
Guangzhou 4
Nanjing 4
Nis 4
Phoenix 4
Porto 4
Provo 4
Rochester 4
South Jordan 4
Bogotá 3
Buffalo 3
Kenilworth 3
Latina 3
Palestrina 3
Paris 3
Querétaro City 3
Ras al-Khaimah 3
Redwood City 3
Taiyuan 3
Turin 3
Amsterdam 2
Asheville 2
Augusta 2
Bari 2
Billings 2
Bologna 2
Bussolengo 2
Cairo 2
Campo Grande 2
Casoria 2
Totale 5.187
Salva come PNG Salva come JPEG
Nome #
Admission heart rate and in-hospital course of patients with Takotsubo syndrome 138
Eligibility for the subcutaneous implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy 110
Effects of different statin types and dosages on systolic/diastolic blood pressure. Retrospective analysis of 24-hour ambulatory blood pressure database 106
A next-generation sequencing approach to identify gene mutations in early-and late-onset hypertrophic cardiomyopathy patients of an Italian cohort 105
Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy 100
Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy 95
Prognostic implications of defibrillation threshold testing in patients with hypertrophic cardiomyopathy 93
24-Hour ambulatory blood pressure levels and control in a large cohort of adult outpatients with different classes of obesity 93
null 91
Clinical Impact of Nonsustained Ventricular Tachycardia Recorded by the Implantable Cardioverter-Defibrillator in Patients with Hypertrophic Cardiomyopathy. 91
QT spatial dispersion and sudden cardiac death in hypertrophic cardiomyopathy. time for reappraisal. 90
RyR2 common gene variant G1886S and the risk of ventricular arrhythmias in ICD patients with heart failure. 87
Nocturnal blood pressure patterns and cardiovascular outcomes in patients with masked hypertension 87
Distinguishing hypertension from hypertrophic cardiomyopathy as a cause of left ventricular hypertrophy 86
Tortuosity, Recurrent Segments, and Bridging of the Epicardial Coronary Arteries in Patients With the Takotsubo Syndrome 86
Long-term management of Takotsubo syndrome: a not-so-benign condition 85
Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m.4277T > C mitochondrial tRNA(Ile) mutation causing hypertrophic cardiomyopathy 84
Restrictive cardiomyopathy and pseudoxanthoma elasticum skin lesions. 84
Therapeutic Approach to Hypertension Urgencies and Emergencies During Acute Coronary Syndrome 84
Oxidative stress and cardiovascular disease 83
Erythropoietin and the heart: facts and perspectives. 81
Growth factors in preeclampsia: A vascular disease model. A failed vasodilation and angiogenic challenge from pregnancy onwards? 80
Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy 80
Heart failure progression in hypertrophic cardiomyopathy, Possible insights from cardiopulmonary exercise testing 80
Myocardial Repolarization Dispersion and Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy 79
Outcomes of early invasive treatment strategy in elderly patients with non-ST elevation acute coronary syndromes 76
Novel Imaging and Genetic Risk Markers in Takotsubo Syndrome 75
Cardiologic assesment of surviving family members of young victims of sudden cardiac death: diagnostic yeld. 74
Patterns of left ventricular longitudinal strain and strain rate in Olympic athletes 74
Current patterns of beta-blocker prescription in cardiac amyloidosis. an Italian nationwide survey 74
Tp-Te interval predicts heart rate reduction after fingolimod administration in patients with multiple sclerosis 74
Calcium Channel Blockers and Hypertension. 71
Clinical management of patients with hypertension and high cardiovascular risk in specialised centers and in general practice. Analysis from an Italian Survey Questionnaire 71
Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy 71
Recombinant human insulin-like growth factor-1: a new cardiovascolar disease treatment option? 70
Electrocardiographic changes in focal takotsubo syndrome. a case report 69
Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New outlook and dose association study (EPAMINONDAS) 68
Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative group. 68
null 68
null 67
Safety and efficacy of anti-tachycardia pacing in patients with hypertrophic cardiomyopathy implanted with an ICD 67
Three-Dimensional Echocardiographic Characterization of Patients with Left Ventricular Noncompaction 66
Simultaneous Takotsubo syndrome in two sisters 66
Severe Left Ventricular Wall Thinning and Extensive Fibrosis Without Evolution to End Stage Disease in a Patient With Hypertrophic Cardiomyopathy 65
Long-Term Outcome of Acute Coronary Syndromes in Young Patients 65
Lack of Influence of the Androgen Receptor Gene CAG-Repeat Polymorphism on Clinical and Electrocardiographic Manifestations of the Brugada Syndrome in Man. 65
Electrocardiographic evolution in patients with hypertrophic cardiomyopathy who develop a left ventricular apical aneurysm 65
Autonomic cardiovascular control and cardiac arrhythmia in two pregnant women with hypertrophic cardiomyopathy: Insights from ICD monitoring 63
Left ventricular remodeling in hypertrophic cardiomyopathy: an overview of current knowledge 63
Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy 62
Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease Survey 62
Clinical translation of genetic testing in TTR Amyloidosis. genotype-phenotype correlations, management of asymptomatic carriers and familial screening 61
Determinants of peak oxygen uptake in patients with hypertrophic cardiomyopathy: a single-center study 61
Unexpectedly Low Mutation Rates in Beta-Myosin Heavy Chain and Cardiac Myosin Binding Protein Genes in Italian Patients With Hypertrophic Cardiomyopathy 61
Genetic susceptibility to cerebrovascular accidents. 61
Functional cross-talk between angiotensin II and epidermal growth factor receptors in NIH3T3 fibroblasts 60
Favourable impact of statin use on diastolic blood pressure levels: analysis of a large database of 24-hour ambulatory blood pressure monitoring 60
Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease 59
Coronavirus disease 2019 in patients with cardiovascular disease. clinical features and implications on cardiac biomarkers assessment 59
Risk of Sudden Death and Outcome in Patients With Hypertrophic Cardiomyopathy With Benign Presentation and Without Risk Factors 57
Risk stratification in hypertrophic cardiomyopathy. Insights from genetic analysis and cardiopulmonary exercise testing 57
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 57
Spatial QT dispersion predicts non-sustained ventricula tachycardia and correlates with a confined systo-diastolic dysfunction un hypertrophic cardiomyopathy 56
Clinical outcomes in adult athletes with hypertrophic cardiomyopathy: a 7-year follow-up study 54
IGF-1 and atherothrombosis: relevance to pathophysiology and therapy 53
null 52
Long-Term Tolerability and Efficacy of the Fixed Combination of Manidipine and Delapril in Patients with Essential Hypertension 51
Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular disease? 51
Nitric oxide release is impaired in hypertensives with familial history of stroke 51
Congenital Accessory Mitral Valve Tissue Anomaly in a Patient with Genetically Confirmed Hypertrophic Cardiomyopathy 50
Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin cardiac amyloidosis 50
Incidence, determinants and prognostic relevance of dyspnea at admission in patients with Takotsubo syndrome. results from the international multicenter GEIST registry. 50
High Risk for Sudden Death Identified by Electrocardiographic Loop Recording in a Patient With Hypertrophic Cardiomyopathy Without Major Risk Factors 49
Subcutaneous implantable cardioverter defibrillator in cardiomyopathies and channelopathies 49
Arterial thrombotic events and acute coronary syndromes with cancer drugs: Are growth factors the missed link? What both cardiologist and oncologist should know about novel angiogenesis inhibitors 49
Transcatheter aortic valve replacement for aortic regurgitation after septal myectomy in patients with obstructive hypertrophic cardiomyopathy 49
A Novel Nonsense Pathogenic TTN Variant Identified in a Patient with Severe Dilated Cardiomyopathy 48
Response to letter from Madias regarding our article “Admission heart rate and in-hospital course of patients with Takotsubo syndrome” 48
New oral anticoagulants in non-valvular atrial fibrillation. 46
Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies 44
An atypical clinical presentation of renovascular hypertension. 44
The many faces of arterial hypertension in hypertrophic cardiomyopathy and its phenocopies: bystander, consequence, modifier 44
Risk stratification in transthyretin-related cardiac amyloidosis 43
Cardiovascular risk and the COVID-19 pandemic: a retrospective observational study in a population of healthcare professionals 41
Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy 41
Incidence and determinants of high-sensitivity troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patients 41
Clinical characteristics of patients with takotsubo syndrome recurrence: An observational study with long-term follow-up 41
Real-world versus trial patients with transthyretin amyloid cardiomyopathy 41
Clinical Course of Pregnancy and Long-Term Follow-Up After Delivery in Hypertrophic Cardiomyopathy 39
Yield of bone scintigraphy screening for transthyretin-related cardiac amyloidosis in different conditions. Methodological issues and clinical implications 38
Long QTc in hypertrophic cardiomyopathy. A consequence of structural myocardial damage or a distinct genetic disease? 37
Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: Data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study 37
The neglected issue of cardiac amyloidosis in trials on heart failure with preserved ejection fraction in the elderly 37
Reply to the letter “Takotsubo syndrome: Any more covariates of its recurrence?” 37
A plea for smoking-free policies in COVID-19 times: cardiovascular prevention as an ally in coronavirus containment 36
Takotsubo syndrome. hyperthyroidism, pheochromocytoma, or both? A case report 36
The natural history of hypertrophic cardiomyopathy 35
Substrates of scar-related ventricular arrhythmia in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study 35
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy. a multicentre network study 34
Insights from cardiopulmonary exercise testing in pediatric patients with hypertrophic cardiomyopathy 34
Totale 6.381
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.454
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.454
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020690 0 0 0 0 0 0 181 150 146 104 56 53
2020/2021591 55 50 21 25 18 32 33 42 62 93 120 40
2021/20221.259 17 51 110 85 195 36 30 131 77 70 259 198
2022/20231.328 206 274 93 89 138 116 31 91 110 43 89 48
2023/20241.019 52 123 48 121 88 186 30 74 6 111 89 91
2024/20251.087 56 149 194 152 227 237 72 0 0 0 0 0
Totale 7.632